AI assistant
Sending…
Cryoport, Inc. — Director's Dealing 2022
May 4, 2022
32876_dirs_2022-05-03_6c7fd450-3a05-4d30-a2a5-b5e60f3a3687.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2022-04-29
Reporting Person: Mandalam Ramkumar (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-29 | Common Stock | A | 7203 | — | Acquired | 7203 | Direct |
| 2022-04-30 | Common Stock | M | 2708 | — | Acquired | 9911 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-30 | Restricted Stock Rights | $ | M | 2708 | Disposed | Common Stock (2708) | Direct | |
| 2022-04-29 | Option (Right to Buy Common Stock) | $22.56 | A | 13981 | Acquired | 2029-04-29 | Common Stock (13981) | Direct |
Footnotes
F1: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
F2: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date.
F3: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022.
More from Cryoport, Inc.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 3